本页面由Tiger Trade Technology Pte. Ltd.提供服务

Denali Therapeutics Inc.

18.29
-0.6600-3.48%
成交量:39.54万
成交额:731.25万
市值:29.24亿
市盈率:-6.45
高:18.82
开:18.82
低:18.23
收:18.95
52周最高:27.30
52周最低:13.75
股本:1.60亿
流通股本:1.51亿
量比:0.67
换手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
净资产收益率:-54.93%
总资产收益率:-29.15%
市净率:3.50
市盈率(LYR):-6.16

数据加载中...

2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/12

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/08

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

重要事件披露

8-K - Current report
2021/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/26

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K - Current report
2021/02/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

重要事件披露

8-K - Current report
2021/02/10

重要事件披露

8-K/A [Amend] - Current report
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals